Inspire Trust Co. N.A. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 23.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,200 shares of the healthcare conglomerate's stock after purchasing an additional 2,098 shares during the period. UnitedHealth Group comprises about 1.4% of Inspire Trust Co. N.A.'s investment portfolio, making the stock its 15th largest position. Inspire Trust Co. N.A.'s holdings in UnitedHealth Group were worth $5,666,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $28,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the 4th quarter valued at about $30,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group during the fourth quarter worth about $30,000. Institutional investors and hedge funds own 87.86% of the company's stock.
Analyst Ratings Changes
Several brokerages have recently commented on UNH. Raymond James downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a research note on Monday. Hsbc Global Res downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 22nd. Truist Financial reaffirmed a "buy" rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research note on Monday. Finally, JPMorgan Chase & Co. lowered their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a report on Thursday, May 15th. One analyst has rated the stock with a sell rating, seven have issued a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $441.87.
Check Out Our Latest Stock Report on UNH
UnitedHealth Group Price Performance
UnitedHealth Group stock opened at $303.08 on Thursday. The firm has a market capitalization of $274.93 billion, a P/E ratio of 19.55, a PEG ratio of 1.37 and a beta of 0.56. The business has a 50-day moving average of $460.62 and a 200-day moving average of $508.74. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the business posted $6.91 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 2.77%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.
Insider Buying and Selling
In other news, CFO John F. Rex purchased 17,175 shares of the company's stock in a transaction on Friday, May 16th. The shares were purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the purchase, the chief financial officer now directly owns 203,796 shares of the company's stock, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Stephen J. Hemsley acquired 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders acquired 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is owned by corporate insiders.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report